Bell Margaret Smith 4

What Happened

• Margaret Bell Smith, a director of Tonix Pharmaceuticals (TNXP), received a grant of 22,700 derivative securities (option award) on 2026-05-12. The reported acquisition price is $0.00, indicating no cash was paid by the insider for the award. This was a grant/award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (appears to be timely).
• Securities: 22,700 derivative shares/options granted at $0.00 (no cash exchanged).
• Vesting: Per footnote, the option vests on the earlier of the one-year anniversary of the grant date or the Issuer's 2027 Annual Meeting of Stockholders.
• Shares owned after transaction: Not stated in the summary information provided in this filing.
• Transaction nature: Award/grant under the Issuer's 2026 Stock Incentive Plan (transaction code A).

Context

• This is a compensation-related option grant to a director. Such awards are common for director compensation and do not by themselves indicate immediate buying or selling sentiment. The footnote clarifies vesting timing; the award is not an exercised option or cash sale.